Skip to main content

Subu Nambi

Analyst

Guggenheim Securities

Equibles does not estimate personal net worth.

About Subu Nambi

Subu Nambi is recorded as Analyst at Guggenheim Securities. Subu Nambi has spoken on 3 earnings calls across 2 companies, most recently for 10x Genomics, Inc. on February 12, 2026. Those appearances were for 10x Genomics, Inc. (TXG) and Repligen Corp (RGEN). The companies whose calls Subu Nambi spoke on are classified in the Healthcare sector.

Subu Nambi on recent calls

“Looking ahead to AGBT, how are you thinking about competitive dynamics from some other players launching solutions this year, and what levers can you pull to stay ahead from a share perspective?”
Analyst — Guggenheim Securities, 10x Genomics, Inc. Q4 FY2025 Earnings Call ·
“Olivia, thank you for sharing all the details. Investors would like tangible KPIs to track progress towards the 5% growth of the market that you mentioned today.”
Analyst — Guggenheim Securities, Repligen Corp Q2 FY2025 Earnings Call ·
“On growth margin was a bit weaker than expected in the quarter.”
Analyst — Guggenheim Securities, 10x Genomics, Inc. Q4 FY2024 Earnings Call ·

Affiliation history

  • Guggenheim Securities

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity